Ventyx Biosciences
Ventyx Biosciences is a clinical-stage biopharmaceutical company developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. Our expertise in medicinal chemistry, structural biology, and immunology enables the discovery of differentiated small molecule therapeutics for conditions with high unmet medical need, and our extensive experience in clinical development allows the rapid progression of these drugs through clinical trials. Our lead portf
Basic Information
- Category: Immunology
- Founded: 2018
- Headquarters: Encinitas, CA
- Website: ventyxbio.com
Documented Facts
- Email: info@ventyxbio.com (No linked source recorded for this statement.)
Evidence and Sources
- Ventyx Biosciences — Official Site (official)
- Ventyx Biosciences on linkedin (social)
Citation Guidance
Explore Immunology profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Ventyx Biosciences.
- Canonical profile: https://brandsource.ai/brands/ventyx-biosciences
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/ventyx-biosciences/json-ld
- Citation profile API: https://brandsource.ai/api/brands/ventyx-biosciences/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (81/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-27T08:35:03.851Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Ventyx Biosciences is a clinical-stage biopharmaceutical company developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. Our expertise in medicinal chemistry, structural biology, and immunology enables the discovery of differentiated small molecule therapeutics for conditions with high unmet medical need, and our extensive experience in clinical development allows the rapid progression of these drugs through clinical trials. Our lead portf
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.